![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Luxembourg | Publication | March 2023
The ELTIF 2.0 Regulation, amending current ELTIF Regulation (EU) 2015/760, was published in the EU’s Official Journal on 20 March 2023 (ELTIF 2). Please see L_2023080EN.01000101.xml (europa.eu).
ELTIF 2 will enter into force on 9 April 2023 and will apply from 10 January 2024.
ELTIFs, which are currently authorized must comply with the ELTIF 2 regime by 11 January 2029, unless they are not raising additional capital.
New ELTIFs authorized before 10 January 2024 may choose to be established under the ELTIF 2 regime.
The ELTIF 2 regime brings new attractive possibilities for this investment product, such as:
Please contact us for additional information on the topic.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Over the past two years, Spain has significantly strengthened its foreign investment screening mechanism, and all acquisitions by foreign investors (as defined below) of a Spanish entity active in a strategic sector are subject to prior authorisation by the Ministry of Industry, Commerce and Tourism (“MoICT”).
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023